Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway. (Q50932558)
Jump to navigation
Jump to search
scientific article published on 5 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway. |
scientific article published on 5 June 2013 |
Statements
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway. (English)
1 reference
1 reference
1 reference
1 reference
Adrien Kissenpfennig
1 reference
Lana McClements
1 reference
Anita Yakkundi
1 reference
Angelos Papaspyropoulos
1 reference
Hannah Harrison
1 reference
Matthew P Ablett
1 reference
Hayley D McKeen
1 reference
Rachel Bennett
1 reference
Christopher Donley
1 reference
Stuart McIntosh
1 reference
Helen O McCarthy
1 reference
Eric O'Neill
1 reference
5 June 2013
1 reference
19
1 reference
14
1 reference
3881-3893
1 reference